_id
691854ea3c536f8df23178ef
Ticker
0FGL.LSE
Name
Nexus AG
Exchange
LSE
Address
Irmastrasse 1, Donaueschingen, Germany, 78166
Country
UK
Sector
Industry
Currency
EUR
Website
https://www.nexus-ag.de
Description
Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospitals information systems, mobile solutions, digital charts and medication, PDMS and device connection, care documentation, appointment and resource management, OP management and CSSD, emergency, medical archive and VNA, patient portal, and diagnostics solutions for hospitals and clinics. The company also provides human genetics, molecular pathology, HBOC, specialized laboratories, special diagnostics, gynecological hospital, ophthalmology, advanced reporting, MARIS healthcare GmbH, and ViREQ software solutions GmbH solutions for diagnostics. In addition, it offers radiology and VNA solutions consisting of radiology information system, vendor neutral archive, PACS, teleradiology portal, telemedicine portal, referral portal, patient portal for images and diagnostic findings, webviewer, telemedicine networking, and DICOM RT-viewer; and residential and psychiatry solutions. Further, the company provides pathology, cytology, and laboratory solutions, as well as IT services comprising integrated solutions. NEXUS AG was founded in 1989 and is headquartered in Donaueschingen, Germany. As of January 3, 2025, Nexus AG was taken private.
Last Close
71.7
Volume
-
Current Price
71.7
Change
0
Last Updated
2025-11-25T10:09:39.555Z
Image
https://logo.clearbit.com/www.nexus-ag.de
Ipo Date
-
Market Cap
1119222656
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
70741000
Cost Of Revenue
9839000
Gross Profit
60902000
Operating Expenses
50345000
Operating Income
10557000
Interest Expense
631000
Pretax Income
10617000
Net Income
7560000
Eps
0.4385914022161629
Dividends Per Share
-3970000
Shares Outstanding
15733000
Income Tax Expense
3266000
EBITDA
16015000
Operating Margin
14.923453160119307
Total Other Income Expense Net
60000
Cash
48819000
Short Term Investments
95298000
Receivables
63297000
Inventories
5146000
Total Current Assets
222696000
Property Plant Equipment
30839000
Total Assets
478186000
Payables
10619000
Short Term Debt
10680000
Long Term Debt
-
Total Liabilities
180791000
Equity
293927000
Depreciation
4767000
Change In Working Capital
-11257000
Cash From Operations
2890000
Capital Expenditures
1464000
Cash From Investing
19795000
Cash From Financing
-6238000
Net Change In Cash
16733000
PE
0.6402
PB
4.20476138633062
ROE
2.572067213968094
ROA
1.5809747671408196
FCF
1426000
Fcf Percent
0.02015804130560778
Piotroski FScore
3
Health Score
45
Deep Value Investing Score
7
Defensive Investing Score
7.5
Dividend Investing Score
5
Economic Moat Investing Score
7.3
Garp Investing Score
3.5
Growth Investing Score
3
Momentum Investing Score
4.5
Net Net Investing Score
4
Quality Investing Score
6.5
Value Investing Score
5.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
70741000
Quarters > 0 > income Statement > cost Of Revenue
9839000
Quarters > 0 > income Statement > gross Profit
60902000
Quarters > 0 > income Statement > operating Expenses
50345000
Quarters > 0 > income Statement > operating Income
10557000
Quarters > 0 > income Statement > interest Expense
631000
Quarters > 0 > income Statement > pretax Income
10617000
Quarters > 0 > income Statement > net Income
7560000
Quarters > 0 > income Statement > eps
0.4385914022161629
Quarters > 0 > income Statement > dividends Per Share
-3970000
Quarters > 0 > income Statement > shares Outstanding
17237000
Quarters > 0 > income Statement > income Tax Expense
3266000
Quarters > 0 > income Statement > EBITDA
16015000
Quarters > 0 > income Statement > operating Margin
14.923453160119307
Quarters > 0 > income Statement > total Other Income Expense Net
60000
Quarters > 0 > balance Sheet > cash
48819000
Quarters > 0 > balance Sheet > short Term Investments
95298000
Quarters > 0 > balance Sheet > receivables
63297000
Quarters > 0 > balance Sheet > inventories
5146000
Quarters > 0 > balance Sheet > total Current Assets
222696000
Quarters > 0 > balance Sheet > property Plant Equipment
30839000
Quarters > 0 > balance Sheet > total Assets
478186000
Quarters > 0 > balance Sheet > payables
10619000
Quarters > 0 > balance Sheet > short Term Debt
10680000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
180791000
Quarters > 0 > balance Sheet > equity
293927000
Quarters > 0 > cash Flow > net Income
10538000
Quarters > 0 > cash Flow > depreciation
4767000
Quarters > 0 > cash Flow > change In Working Capital
-11257000
Quarters > 0 > cash Flow > cash From Operations
2890000
Quarters > 0 > cash Flow > capital Expenditures
1464000
Quarters > 0 > cash Flow > cash From Investing
19795000
Quarters > 0 > cash Flow > cash From Financing
-6238000
Quarters > 0 > cash Flow > net Change In Cash
16733000
Quarters > 0 > ratios > PE
0.4385914022161629
Quarters > 0 > ratios > PB
4.20476138633062
Quarters > 0 > ratios > ROE
2.572067213968094
Quarters > 0 > ratios > ROA
1.5809747671408196
Quarters > 0 > ratios > FCF
1426000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.02015804130560778
Quarters > 0 > health Score
45
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
70022000
Quarters > 1 > income Statement > cost Of Revenue
9949000
Quarters > 1 > income Statement > gross Profit
60073000
Quarters > 1 > income Statement > operating Expenses
48760000
Quarters > 1 > income Statement > operating Income
11313000
Quarters > 1 > income Statement > interest Expense
368000
Quarters > 1 > income Statement > pretax Income
11899000
Quarters > 1 > income Statement > net Income
8237000
Quarters > 1 > income Statement > eps
0.47772880176313653
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
17242000
Quarters > 1 > income Statement > income Tax Expense
3660000
Quarters > 1 > income Statement > EBITDA
16943000
Quarters > 1 > income Statement > operating Margin
16.15635086115792
Quarters > 1 > income Statement > total Other Income Expense Net
586000
Quarters > 1 > balance Sheet > cash
32086000
Quarters > 1 > balance Sheet > short Term Investments
119599000
Quarters > 1 > balance Sheet > receivables
61471000
Quarters > 1 > balance Sheet > inventories
5013000
Quarters > 1 > balance Sheet > total Current Assets
229733000
Quarters > 1 > balance Sheet > property Plant Equipment
31553000
Quarters > 1 > balance Sheet > total Assets
476385000
Quarters > 1 > balance Sheet > payables
9605000
Quarters > 1 > balance Sheet > short Term Debt
10242000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
185514000
Quarters > 1 > balance Sheet > equity
287185000
Quarters > 1 > cash Flow > net Income
11259000
Quarters > 1 > cash Flow > depreciation
4676000
Quarters > 1 > cash Flow > change In Working Capital
19547000
Quarters > 1 > cash Flow > cash From Operations
34199000
Quarters > 1 > cash Flow > capital Expenditures
1934000
Quarters > 1 > cash Flow > cash From Investing
-19536000
Quarters > 1 > cash Flow > cash From Financing
-1462000
Quarters > 1 > cash Flow > net Change In Cash
13048000
Quarters > 1 > ratios > PE
0.47772880176313653
Quarters > 1 > ratios > PB
4.3047213468670025
Quarters > 1 > ratios > ROE
2.868186012500653
Quarters > 1 > ratios > ROA
1.7290636774877461
Quarters > 1 > ratios > FCF
32265000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.46078375367741564
Quarters > 1 > health Score
64
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
70658000
Quarters > 2 > income Statement > cost Of Revenue
10907000
Quarters > 2 > income Statement > gross Profit
59751000
Quarters > 2 > income Statement > operating Expenses
48584000
Quarters > 2 > income Statement > operating Income
11167000
Quarters > 2 > income Statement > interest Expense
464000
Quarters > 2 > income Statement > pretax Income
12008000
Quarters > 2 > income Statement > net Income
10515000
Quarters > 2 > income Statement > eps
0.6089018144521268
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
17268794
Quarters > 2 > income Statement > income Tax Expense
1112000
Quarters > 2 > income Statement > EBITDA
17757000
Quarters > 2 > income Statement > operating Margin
15.804296753375413
Quarters > 2 > income Statement > total Other Income Expense Net
841000
Quarters > 2 > balance Sheet > cash
19038000
Quarters > 2 > balance Sheet > short Term Investments
98193000
Quarters > 2 > balance Sheet > receivables
59458000
Quarters > 2 > balance Sheet > inventories
4551000
Quarters > 2 > balance Sheet > total Current Assets
189066000
Quarters > 2 > balance Sheet > property Plant Equipment
32403000
Quarters > 2 > balance Sheet > total Assets
437733000
Quarters > 2 > balance Sheet > payables
10190000
Quarters > 2 > balance Sheet > short Term Debt
10558000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
154774000
Quarters > 2 > balance Sheet > equity
279244000
Quarters > 2 > cash Flow > net Income
11504000
Quarters > 2 > cash Flow > depreciation
5284000
Quarters > 2 > cash Flow > change In Working Capital
5013000
Quarters > 2 > cash Flow > cash From Operations
23825000
Quarters > 2 > cash Flow > capital Expenditures
4745000
Quarters > 2 > cash Flow > cash From Investing
-19719000
Quarters > 2 > cash Flow > cash From Financing
-2418000
Quarters > 2 > cash Flow > net Change In Cash
1495000
Quarters > 2 > ratios > PE
0.6089018144521268
Quarters > 2 > ratios > PB
4.434016594089757
Quarters > 2 > ratios > ROE
3.7655240578132387
Quarters > 2 > ratios > ROA
2.4021492553679984
Quarters > 2 > ratios > FCF
19080000
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.27003311726909907
Quarters > 2 > health Score
66
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
63140000
Quarters > 3 > income Statement > cost Of Revenue
49048000
Quarters > 3 > income Statement > gross Profit
14092000
Quarters > 3 > income Statement > operating Expenses
3392000
Quarters > 3 > income Statement > operating Income
10700000
Quarters > 3 > income Statement > interest Expense
590000
Quarters > 3 > income Statement > pretax Income
11099000
Quarters > 3 > income Statement > net Income
7901000
Quarters > 3 > income Statement > eps
0.45794934214339533
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
17253000
Quarters > 3 > income Statement > income Tax Expense
3214000
Quarters > 3 > income Statement > EBITDA
16328000
Quarters > 3 > income Statement > operating Margin
16.94646816598036
Quarters > 3 > income Statement > total Other Income Expense Net
399000
Quarters > 3 > balance Sheet > cash
17543000
Quarters > 3 > balance Sheet > short Term Investments
94574000
Quarters > 3 > balance Sheet > receivables
53298000
Quarters > 3 > balance Sheet > inventories
4093000
Quarters > 3 > balance Sheet > total Current Assets
175475000
Quarters > 3 > balance Sheet > property Plant Equipment
31997000
Quarters > 3 > balance Sheet > total Assets
415345000
Quarters > 3 > balance Sheet > payables
5797000
Quarters > 3 > balance Sheet > short Term Debt
10054000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
146140000
Quarters > 3 > balance Sheet > equity
265841000
Quarters > 3 > cash Flow > net Income
7901000
Quarters > 3 > cash Flow > depreciation
4640000
Quarters > 3 > cash Flow > change In Working Capital
-7854000
Quarters > 3 > cash Flow > cash From Operations
105000
Quarters > 3 > cash Flow > capital Expenditures
1362000
Quarters > 3 > cash Flow > cash From Investing
6844000
Quarters > 3 > cash Flow > cash From Financing
-2788000
Quarters > 3 > cash Flow > net Change In Cash
4509000
Quarters > 3 > ratios > PE
0.45794934214339533
Quarters > 3 > ratios > PB
4.65330818045373
Quarters > 3 > ratios > ROE
2.9720772943225464
Quarters > 3 > ratios > ROA
1.9022740131697746
Quarters > 3 > ratios > FCF
-1257000
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
-0.019908140639847957
Quarters > 3 > health Score
45
Valuation > metrics > PE
0.6402
Valuation > metrics > PB
4.20476138633062
Valuation > final Score
57.9523861366938
Valuation > verdict
26.7% Undervalued
Profitability > metrics > ROE
2.572067213968094
Profitability > metrics > ROA
3.394762366634336
Profitability > metrics > Net Margin
0.1068687182821843
Profitability > final Score
31
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.6150881001064891
Risk > metrics > Interest Coverage
16.730586370839937
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
10.45570214564064
Liquidity > metrics > Quick Ratio
10.214094558429974
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
56.95278653132998
Prev Valuations > 1
55.65983405910244
Prev Valuations > 2
53.466918195462696
Prev Profitabilities > 0
34
Prev Profitabilities > 1
47
Prev Profitabilities > 2
38
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
88
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:52:40.016Z
Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospitals information systems, mobile solutions, digital charts and medication, PDMS and device connection, care documentation, appointment and resource management, OP management and CSSD, emergency, medical archive and VNA, patient portal, and diagnostics solutions for hospitals and clinics. The company also provides human genetics, molecular pathology, HBOC, specialized laboratories, special diagnostics, gynecological hospital, ophthalmology, advanced reporting, MARIS healthcare GmbH, and ViREQ software solutions GmbH solutions for diagnostics. In addition, it offers radiology and VNA solutions consisting of radiology information system, vendor neutral archive, PACS, teleradiology portal, telemedicine portal, referral portal, patient portal for images and diagnostic findings, webviewer, telemedicine networking, and DICOM RT-viewer; and residential and psychiatry solutions. Further, the company provides pathology, cytology, and laboratory solutions, as well as IT services comprising integrated solutions. NEXUS AG was founded in 1989 and is headquartered in Donaueschingen, Germany. As of January 3, 2025, Nexus AG was taken private.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Medium
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Nexus AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2025-06-30)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.